Drugs / TDX105
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05289726 | Apr → Jul 2022 | colorectal cancer, hand-foot syndrome | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDX105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05289726 ↗ |
| Known as | Danxiong Granules | “the traditional Chinese medicine compound Danxiong Granules (TDX105) has shown significant therapeutic benefit for HFSR.” PMID 41282614 ↗ Nov 2025 |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine compound Danxiong Granules (TDX105)” PMID 41282614 ↗ Nov 2025 |
| Route | Other | “soak hands and feet for 30 minutes each time” NCT05289726 ↗ |